title: Prostate cancer: CYP17A1 inhibitor failure-lessons for future drug development.
authors.affiliation: Department of Cancer Biology, Lerner Research Institute, 9500 Euclid Avenue, Cleveland Clinic, Cleveland, OH 44195, USA.
authors.forename: Nima
authors.initials: N
authors.lastname: Sharifi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D014408:Biomarkers, Tumor / Q000097:blood*; D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*
chemical_list: D014408:Biomarkers, Tumor; D017430:Prostate-Specific Antigen
references.citation: Cancer Res. 2012 May 1;72(9):2176-82
references.pmid: 22411952
references.citation: Clin Cancer Res. 2012 Jul 1;18(13):3571-9
references.pmid: 22753664
references.citation: Endocrinology. 2013 Nov;154(11):4010-7
references.pmid: 24002034
references.citation: Prostate Cancer Prostatic Dis. 2014 Jun;17(2):192-8
references.pmid: 24637537
references.citation: J Clin Oncol. 2015 Mar 1;33(7):723-31
references.pmid: 25624429
references.citation: J Steroid Biochem Mol Biol. 2012 Apr;129(3-5):115-28
references.pmid: 22249003
references.citation: N Engl J Med. 2011 May 26;364(21):1995-2005
references.pmid: 21612468
references.citation: Clin Cancer Res. 2014 Mar 1;20(5):1335-44
references.pmid: 24418642
references.citation: N Engl J Med. 2013 Jan 10;368(2):138-48
references.pmid: 23228172